Geraldine Clarke

Geraldine Clarke

Auto-generated profile, based on publicly available information

Geraldine Clarke

The Health Foundation, London, UK

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2011 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
GCGeraldine M Clarke
Geraldine M Clarke
CACarl A Anderson
Carl A Anderson
FPFredrik H Pettersson
Fredrik H Pettersson
LCLon R Cardon
Lon R Cardon
AMAndrew P Morris
Andrew P Morris
KZKrina Zondervan
Krina Zondervan

16 December 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MNMalaria Genomic Epidemiology Network
Malaria Genomic Epidemiology Network
GBGavin Band
Gavin Band
QLQuang Si Le
Quang Si Le
GCGeraldine M. Clarke
Geraldine M. Clarke
KKKatja Kivinen
Katja Kivinen
DKDominic P. Kwiatkowski
Dominic P. Kwiatkowski
The human genetic factors that affect resistance to infectious disease are poorly understood. Here we report a genome-wide association study in 17,000 severe malaria cases and population controls from 11 countries, informed by sequencing of family trios and by direct typing of candidate loci in an additional 15,000 samples. We identify five replicable associations with genome-wide levels of evidence including a newly implicated variant on chromosome 6. Jointly, these variants account for around one-tenth of the heritability of severe malaria, which we estimate as ~23% using genome-wide genotypes. We interrogate available functional data and discover an erythroid-specific transcription start site underlying the known association inATP2B4, but are unable to identify a likely causal mechanism at the chromosome 6 locus. Previously reported HLA associations do not replicate in these samples. This large dataset will provide a foundation for further research on the genetic determinants of malaria resistance in diverse populations.

16 June 2017 in Science
Verified
Journal Article
Open access
PDF file
ELEllen M. Leffler
Ellen M. Leffler
GBGavin Band
Gavin Band
GBGeorge B. Busby
George B. Busby
KKKatja Kivinen
Katja Kivinen
QLQuang Si Le
Quang Si Le
MNMalaria Genomic Epidemiology Network
Malaria Genomic Epidemiology Network
The malaria parasite Plasmodium falciparum invades human red blood cells by a series of interactions between host and parasite surface proteins. By analyzing genome sequence data from human populations, including 1269 individuals from sub-Saharan Africa, we identify a diverse array of large copy-number variants affecting the host invasion receptor genes GYPA and GYPB. We find that a nearby association with severe malaria is explained by a complex structural rearrangement involving the loss of GYPB and gain of two GYPB-A hybrid genes, which encode a serologically distinct blood group antigen known as Dantu. This variant reduces the risk of severe malaria by 40% and has recently increased in frequency in parts of Kenya, yet it appears to be absent from west Africa. These findings link structural variation of red blood cell invasion receptors with natural resistance to severe malaria.

20 June 2019 in BMJ
Verified
Journal Article
Open access
PDF file
GCGeraldine M Clarke
Geraldine M Clarke
SCStefano Conti
Stefano Conti
AWArne T Wolters
Arne T Wolters
ASAdam Steventon
Adam Steventon
What you need to know Assessing the impact of healthcare interventions is critical to inform future decisions Compare observed outcomes with what you would have expected if the intervention had not been implemented A wide range of routinely collected data is available for the evaluation of healthcare interventions

9 January 2017 in eLife
Verified
Journal Article
Open access
GCGeraldine M Clarke
Geraldine M Clarke
KRKirk Rockett
Kirk Rockett
KKKatja Kivinen
Katja Kivinen
CHChristina Hubbart
Christina Hubbart
AJAnna E Jeffreys
Anna E Jeffreys
MCMalariaGEN Consortium
MalariaGEN Consortium
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is believed to confer protection against Plasmodium falciparum malaria, but the precise nature of the protective effect has proved difficult to define as G6PD deficiency has multiple allelic variants with different effects in males and females, and it has heterogeneous effects on the clinical outcome of P. falciparum infection. Here we report an analysis of multiple allelic forms of G6PD deficiency in a large multi-centre case-control study of severe malaria, using the WHO classification of G6PD mutations to estimate each individual’s level of enzyme activity from their genotype. Aggregated across all genotypes, we find that increasing levels of G6PD deficiency are associated with decreasing risk of cerebral malaria, but with increased risk of severe malarial anaemia. Models of balancing selection based on these findings indicate that an evolutionary trade-off between different clinical outcomes of P. falciparum infection could have been a major cause of the high levels of G6PD polymorphism seen in human populations.

10 December 2009 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
GCGeraldine M. Clarke
Geraldine M. Clarke
LCLon R. Cardon
Lon R. Cardon